Shell Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,331
| Closed | -$78K | – | 1327 |
|
|
2023
Q4 | $78K | Sell |
1,331
-401
| -23% | -$23.5K | ﹤0.01% | 1113 |
|
|
2023
Q3 | $75K | Sell |
1,732
-28
| -2% | -$1.21K | ﹤0.01% | 1140 |
|
|
2023
Q2 | $64K | Sell |
1,760
-10
| -0.6% | -$364 | ﹤0.01% | 1194 |
|
|
2023
Q1 | $66K | Sell |
1,770
-6
| -0.3% | -$224 | ﹤0.01% | 1161 |
|
|
2022
Q4 | $80K | Sell |
1,776
-359
| -17% | -$16.2K | ﹤0.01% | 1212 |
|
|
2022
Q3 | $149K | Sell |
2,135
-559
| -21% | -$39K | 0.01% | 1115 |
|
|
2022
Q2 | $181K | Buy |
2,694
+5
| +0.2% | +$336 | 0.01% | 1144 |
|
|
2022
Q1 | $221K | Sell |
2,689
-398
| -13% | -$32.7K | 0.01% | 1144 |
|
|
2021
Q4 | $453K | Buy |
3,087
+22
| +0.7% | +$3.23K | 0.01% | 943 |
|
|
2021
Q3 | $542K | Sell |
3,065
-140
| -4% | -$24.8K | 0.01% | 836 |
|
|
2021
Q2 | $518K | Buy |
+3,205
| New | +$518K | 0.01% | 899 |
|
|
2021
Q1 | – | Sell |
-1,463
| Closed | -$321K | – | 1502 |
|
|
2020
Q4 | $321K | Hold |
1,463
| – | – | 0.01% | 977 |
|
|
2020
Q3 | $243K | Hold |
1,463
| – | – | 0.01% | 981 |
|
|
2020
Q2 | $167K | Buy |
+1,463
| New | +$167K | ﹤0.01% | 1060 |
|